Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.34
- Piotroski Score 2.00
- Grade In-Line
- Symbol (BOLD)
- Company Boundless Bio, Inc. Common Stock
- Price $2.99
- Changes Percentage (-0.66%)
- Change -$0.02
- Day Low $2.98
- Day High $3.07
- Year High $15.24
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $-49,434,000
Income Statement
Quarterly
Annual
Latest News of BOLD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Martin Scorsese illuminates history's boldest saints in Fox Nation series he 'didn't believe could be done'
Martin Scorsese is the driving force behind the captivating docuseries "The Saints," highlighting the remarkable lives of historical saints. From Joan of Arc to Maxmilian Kolbe, the series delves into...
By Fox News | 1 day ago -
Travis Kelce Lands in Buffalo in Bold Multi-Colored Jacket Ahead of Chiefs Game Against Bills
Kansas City Chiefs player, Kelce, arrived in Buffalo in a bold outfit for their game against the Bills. Sporting a $4,200 cashmere jacket, he accessorized with a Cavaliers cap, Celine sunglasses, and ...
By PEOPLE.com | 1 day ago -
Those bold AGI predictions are suddenly looking stretched
Excitement for achieving Artificial General Intelligence (AGI) has been dampened by recent developments showing slow progress in AI model improvements. Predictions of AGI by 2025-2027 are now consider...
By Business Insider | 1 day ago
